Evidence map›Paper›PMID 31546992›Full record

ReviewNutrients2019

Microbial Metabolites of Flavan-3-Ols and Their Biological Activity.

Estefanía Márquez Campos, Peter Stehle, Marie-Christine Simon

Abstract readReview
In one paragraph

Review in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Optimization of anJournal of agricultural and food chemistry · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Estefanía Márquez CamposDepartment of Nutrition and Food Sciences, Nutrition and Microbiota, University of Bonn, 53115 Bonn, Germany. estefania.marquezc@gmail.com.
Peter StehleDepartment of Nutrition and Food Sciences, Nutritional Physiology, University of Bonn, 53115 Bonn, Germany. p.stehle@uni-bonn.de.ORCID 0000-0002-4596-8088
Marie-Christine SimonDepartment of Nutrition and Food Sciences, Nutrition and Microbiota, University of Bonn, 53115 Bonn, Germany. marie-christine.simon@uni-bonn.de.ORCID 0000-0001-6625-1265

Funding

Bundesministerium für Bildung und Forschung 01EA1707
6 · The paper itself

Abstract

Flavan-3-ols are the main contributors to polyphenol intake. Many varying beneficial health effects in humans have been attributed to them, including the prevention of cardiovascular disease and cancer. Nevertheless, the mechanisms by which these flavonoids could exert beneficial functions are not entirely known. Several in vitro studies and in vivo animal models have tried to elucidate the role of the specific colonic metabolites on the health properties that are attributed to the parent compounds since a larger number of ingested flavan-3-ols reach the colon and undergo there microbial metabolism. Many new studies about this topic have been performed over the last few years and, to the best of our knowledge, no scientific literature review regarding the bioactivity of all identified microbial metabolites of flavan-3-ols has been recently published. Therefore, the aim of this review is to present the current status of knowledge on the potential health benefits of flavan-3-ol microbial metabolites in humans while using the latest evidence on their biological activity.

Indexed as

AnimalsBiological AvailabilityColonFlavonoidsGastrointestinal MicrobiomeHumansflavan-3-olFlavonoidsflavonoidsmetabolismmicrobiotapolyphenols

Identifiers

PMID31546992
PMCPMC6836129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.